Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Low serum creatine kinase levels in breast cancer patients: a case-control study.

Pan H, Xia K, Zhou W, Xue J, Liang X, Cheng L, Wu N, Liang M, Wu D, Ling L, Ding Q, Chen L, Zha X, Liu X, Wang S.

PLoS One. 2013 Apr 15;8(4):e62112. doi: 10.1371/journal.pone.0062112. Print 2013.

2.

High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients.

Kong Y, Dai S, Xie X, Xiao X, Lv N, Guo J, Li L, Jia W, Zhang Y, Liu W, Wei W, Xie X.

J Cancer Res Clin Oncol. 2012 Feb;138(2):275-84. doi: 10.1007/s00432-011-1095-9. Epub 2011 Nov 25.

PMID:
22116318
3.
4.
5.

Serum levels of hepatocyte growth factor in patients with breast cancer.

Sheen-Chen SM, Liu YW, Eng HL, Chou FF.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):715-7.

6.

Serum levels of transforming growth factor beta1 in patients with breast cancer.

Sheen-Chen SM, Chen HS, Sheen CW, Eng HL, Chen WJ.

Arch Surg. 2001 Aug;136(8):937-40.

PMID:
11485532
8.

Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary breast cancer patients.

Ahmed HH, Metwally FM, Mahdy ES, Shosha WG, Ramadan SS.

Eur Rev Med Pharmacol Sci. 2012 Jul;16(7):958-65.

PMID:
22953646
9.

Angiogenin expression and prognosis in primary breast carcinoma.

Montero S, Guzmán C, Cortés-Funes H, Colomer R.

Clin Cancer Res. 1998 Sep;4(9):2161-8.

10.

Serum concentration of tumor necrosis factor in patients with breast cancer.

Sheen-Chen SM, Chen WJ, Eng HL, Chou FF.

Breast Cancer Res Treat. 1997 May;43(3):211-5.

PMID:
9150900
11.

Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.

Santillan AA, Delman KA, Beasley GM, Mosca PJ, Hochwald SN, Grobmyer SR, Andtbacka RH, Noyes RD, Kane JM, Ross MI, Tyler DS, Zager JS.

Ann Surg Oncol. 2009 Sep;16(9):2570-8. doi: 10.1245/s10434-009-0563-9. Epub 2009 Jun 19.

PMID:
19543771
12.

Elevated serum levels of creatine kinase BB in breast cancer.

Scambia G, Spina MA, Turriziani A, Trodella L, Iacobelli S.

Eur J Gynaecol Oncol. 1985;6(1):45-8.

PMID:
3971993
13.

Elevated serum creatine kinase BB levels in patients with small cell lung cancer.

Carney DN, Zweig MH, Ihde DC, Cohen MH, Makuch RW, Gazdar AF.

Cancer Res. 1984 Nov;44(11):5399-403.

14.

[Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].

Chen Y, Zheng YH, Lin YY, Hu MH, Chen YS.

Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):842-6. Chinese.

PMID:
22335950
15.

Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.

Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, Reintgen DS.

Am Surg. 1999 Jun;65(6):500-5; discussion 505-6.

PMID:
10366202
16.

Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.

Zarghami N, Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Sismondi P, Diamandis EP.

Br J Cancer. 1996 Feb;73(3):386-90.

17.

[Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].

Tang JH, Zhao JH, Gong JP, Qin JW, Pan LQ, Xu ZY.

Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):210-4. Chinese.

PMID:
17649639
18.

Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.

Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M.

Int J Oncol. 2005 Mar;26(3):721-30.

PMID:
15703829
19.

Serum big endothelin-1 levels in female patients with breast cancer.

Yildirim Y, Gunel N, Coskun U, Sancak B, Bukan N, Aslan S, Cetin A.

Int Immunopharmacol. 2008 Aug;8(8):1119-23. doi: 10.1016/j.intimp.2008.03.023. Epub 2008 Apr 28.

PMID:
18550016
20.

Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.

Ravishankaran P, Karunanithi R.

World J Surg Oncol. 2011 Feb 6;9:18. doi: 10.1186/1477-7819-9-18.

Supplemental Content

Support Center